Legend Biotech Cash Flow Statement Analysis

Operating, investing, and financing activities in billions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Legend Biotech Corporation (LEGN) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-0.16-0.52-0.45-0.40-0.27
Depreciation & Amortization0.020.020.020.010.01
Stock Based Compensation0.070.050.030.020.00
Change in Working Capital0.02-0.070.190.16-0.02
Change in Accounts Receivable0.09-0.100.050.02-0.05
Change in Inventory-0.02-0.01-0.010.000.00
Change in Accounts Payable0.06-0.050.070.000.00
Change in Other Working Capital-0.04-0.030.070.140.03
Other Operating Activities-0.040.090.010.010.05
Net Cash from Operating Activities-0.14-0.39-0.20-0.20-0.22
Investing Activities
Capital Expenditures-0.010.02-0.02-0.04-0.03
Purchases of Investments-2.71-4.86-0.04-0.150.03
Sales/Maturities of Investments1.930.200.000.000.00
Other Investing Activities-0.050.01-0.010.00-0.02
Net Cash from Investing Activities-0.850.09-0.08-0.19-0.02
Financing Activities
Debt Repayment0.000.000.000.000.00
Common Stock Issued0.000.580.380.630.46
Other Financing Activities0.010.000.000.000.00
Net Cash from Financing Activities0.010.790.380.630.62
Summary
Effect of Forex Changes on Cash0.000.000.000.000.00
Net Change in Cash-0.990.490.100.230.37
Cash at Beginning of Period1.280.790.690.460.08
Cash at End of Period0.291.281.400.690.46
Free Cash Flow-0.16-0.51-0.22-0.24-0.25
Supplemental Disclosures
Interest Paid0.000.000.000.000.00
Income Taxes Paid0.000.000.000.00-0.01